Crystallization and preliminary X-ray diffraction analysis of Salmonella typhimurium uridine phosphorylase complexed with 5-fluorouracil

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jun 1;65(Pt 6):601-3. doi: 10.1107/S1744309109016133. Epub 2009 May 22.

Abstract

Uridine phosphorylase (UPh; EC 2.4.2.3) catalyzes the phosphorolytic cleavage of the N-glycosidic bond of uridine to form ribose 1-phosphate and uracil. This enzyme also activates pyrimidine-containing drugs, including 5-fluorouracil (5-FU). In order to better understand the mechanism of the enzyme-drug interaction, the complex of Salmonella typhimurium UPh with 5-FU was cocrystallized using the hanging-drop vapour-diffusion method at 294 K. X-ray diffraction data were collected to 2.2 A resolution. Analysis of these data revealed that the crystal belonged to space group C2, with unit-cell parameters a = 158.26, b = 93.04, c = 149.87 A, alpha = gamma = 90, beta = 90.65 degrees . The solvent content was 45.85% assuming the presence of six hexameric molecules of the complex in the unit cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / metabolism*
  • Binding Sites
  • Crystallization
  • Data Collection
  • Escherichia coli / genetics
  • Fluorouracil / metabolism*
  • Models, Molecular
  • Plasmids
  • Protein Binding
  • Salmonella typhimurium / enzymology
  • Statistics as Topic
  • Temperature
  • Transformation, Bacterial
  • Uridine Phosphorylase / analysis*
  • Uridine Phosphorylase / chemistry
  • Uridine Phosphorylase / isolation & purification
  • Uridine Phosphorylase / metabolism*
  • Water / metabolism
  • X-Ray Diffraction*

Substances

  • Antimetabolites, Antineoplastic
  • Water
  • Uridine Phosphorylase
  • Fluorouracil